KELFAYY
LIVE

Serial Number

99583727

Owner

Merck Sharp & Dohme LLC

Attorney

Lisa M. Dellamura

Filing Date

Jan 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KELFAYY Trademark

Serial Number: 99583727

KELFAYY is a trademark filed by Merck Sharp & Dohme LLC on January 8, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Merck Sharp & Dohme LLC (4 trademarks)

126 East Lincoln Avenue
Rahway, NJ 07065

Entity Type: 16

Trademark Details

Filing Date

January 8, 2026

Registration Date

Not Registered

Published for Opposition

March 3, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2026 CNSA
ASSIGNED TO EXAMINER
Feb 3, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 8, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2026 NWOS
NEW APPLICATION ENTERED
Jan 8, 2026 NWAP